OpenVSafe by OpenVAERS
Search V-safe

CN2-20077-59600

2 vaccinations 2 coded responses 2 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
481 / MI
Registered
2022-04-21
Relationship
Child or adolescent in my care
Guardian
ZDA-32420-52573
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-22
    Dose 2 — Pfizer-BioNTech
  3. 2022-04-21
    Registered in v-safe
  4. 2022-06-23
    Survey response — 6 months, dose 2, dependent
    MedDRA: Cough, Fatigue, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Cough sore throat fatigue
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-12-22
    Survey response — 12 months, dose 2, dependent
    MedDRA: Brain fog, Parosmia, Taste disorder — Feeling: Fair
    Free text: Memory fog and smell/taste alteration
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-29Pfizer-BioNTech No
22021-12-22Pfizer-BioNTech No

Free text

Release 12 — 6 months, dose 2, dependent

2022-06-23

Symptoms: Cough sore throat fatigue

Release 12 — 12 months, dose 2, dependent

2022-12-22

Symptoms: Memory fog and smell/taste alteration

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBrain fog · · ✓
SDCough · · ✓
SDFatigue · · ✓
SDOropharyngeal pain · · ✓
SDParosmia · · ✓
SDTaste disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release